NCT05025865View on ClinicalTrials.gov

HA35 Acute Alcohol Study

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

October 1, 2025

Study Completion Date

October 1, 2026

Conditions
Healthy Controls
Interventions
DRUG

Sodium Hyaluronate

Sodium Hyaluronate of molecular weight 35 kDa will be given in capsule form to the study participants.

DRUG

Placebo

A placebo will be given in capsule form to study participants.

Trial Locations (1)

44195

RECRUITING

Cleveland Clinic, Cleveland

All Listed Sponsors
lead

The Cleveland Clinic

OTHER